Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lohse

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Cancer Treatment and Research Communications|January 16, 2026
Tumor-microbe transkingdom interactions in cancers at body interfaces: mechanisms of neutrophil lifespan extension and functional reprogramming with therapeutic implicationsIslam Mohamed, Stefan Lohse
Journal of Leukocyte Biology|July 15, 2025
Adaptation of the living therapeutic materials concept to the immune sensing of neutrophil granulocytesIslam Mohamed, Kristin Burckhardt, Stefan Lohse
Oncoimmunology|June 14, 2013
EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodiesStefanie Derer, Stefan Lohse, Thomas Valerius
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetranceAssunta Venuti, Stefan Lohse, Massimo Tommasino, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 29, 2010
Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodiesStefan Lohse, Matthias Peipp, Thomas Beyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loopThies Rösner, Stefan Lohse, Matthias Peipp, et al.
Oral Oncology|September 22, 2024
The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotypeAlexander Valcenko, Anabel Zwick, Lissy Schneider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2024
Engineering Dimeric EGFR-directed IgA Antibodies Reveals a Central Role of CD147 during Neutrophil-mediated Tumor Cell Killing of Head and Neck Squamous Cancer CellsAnabel Zwick, Felix Leon Braun, Lennert Jochen Weber, et al.
Oncotarget|September 23, 2015
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicityMatthias Peipp, Stefanie Derer, Stefan Lohse, et al.
Journal of Immunological Methods|August 13, 2019
Monitoring kinetics reveals critical parameters of IgA-dependent granulocyte-mediated anti-tumor cell cytotoxicityAnabel Zwick, Muriel Bernhard, Arne Knoerck, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cancer Treatment and Research Communications|January 16, 2026
Tumor-microbe transkingdom interactions in cancers at body interfaces: mechanisms of neutrophil lifespan extension and functional reprogramming with therapeutic implicationsIslam Mohamed, Stefan Lohse
Journal of Leukocyte Biology|July 15, 2025
Adaptation of the living therapeutic materials concept to the immune sensing of neutrophil granulocytesIslam Mohamed, Kristin Burckhardt, Stefan Lohse
Oncoimmunology|June 14, 2013
EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodiesStefanie Derer, Stefan Lohse, Thomas Valerius
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetranceAssunta Venuti, Stefan Lohse, Massimo Tommasino, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 29, 2010
Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodiesStefan Lohse, Matthias Peipp, Thomas Beyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loopThies Rösner, Stefan Lohse, Matthias Peipp, et al.
Oral Oncology|September 22, 2024
The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotypeAlexander Valcenko, Anabel Zwick, Lissy Schneider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2024
Engineering Dimeric EGFR-directed IgA Antibodies Reveals a Central Role of CD147 during Neutrophil-mediated Tumor Cell Killing of Head and Neck Squamous Cancer CellsAnabel Zwick, Felix Leon Braun, Lennert Jochen Weber, et al.
Oncotarget|September 23, 2015
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicityMatthias Peipp, Stefanie Derer, Stefan Lohse, et al.
Journal of Immunological Methods|August 13, 2019
Monitoring kinetics reveals critical parameters of IgA-dependent granulocyte-mediated anti-tumor cell cytotoxicityAnabel Zwick, Muriel Bernhard, Arne Knoerck, et al.
Pageof 5